Pregnant people use cannabidiol (CBD) to treat nausea, insomnia, anxiety, and pain. However, CBD crosses the placenta and enters the fetal brain, where it can affect several targets important for brain development. While consumption of high doses of CBD during pregnancy has been shown to disrupt offspring neurodevelopment, pain sensitivity, and cognitive behavior in mice, lower doses have not been assessed.
Methodology:
We administered 10 mg/kg/day CBD by oral gavage to pregnant C57Bl6 mice from embryonic day 5 through birth. We used the puzzle box, the forced swim test, and Hargreaves thermal sensitivity behavior tests and electrophysiology to determine how prenatal CBD exposure affects postnatal behavior and prefrontal cortex physiology.
Results:
We show that oral consumption of 10 mg/kg/day CBD during pregnancy increases thermal pain sensitivity in male mouse offspring. Furthermore, the same dose impairs cognition and reduces excitability of the prefrontal cortex in female mouse offspring.
Conclusion:
These data show that lower doses of CBD consumption during pregnancy can impair fetal brain development and postnatal behavior.
VolkowND, HanB, ComptonWM, et al.Self-reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA, 2019; 322(2):167–169; doi: 10.1001/jama.2019.7982
2.
ZauggC, TerplanM, MailmanK, et al.Reasons pregnant people use cannabis to self-treat health conditions during pregnancy: Results from a US population-based survey. Drug Alcohol Rev, 2024; 43(7):1742–1752; doi: 10.1111/dar.13934
3.
StellaN. THC and CBD: Similarities and differences between siblings. Neuron, 2023; 111(3):302–327; doi: 10.1016/j.neuron.2022.12.022
4.
Young-WolffKC, SarovarV, TuckerLY, et al.Self-reported daily, weekly, and monthly cannabis use among women before and during pregnancy. JAMA Netw Open, 2019; 2(7):e196471-e196471; doi: 10.1001/jamanetworkopen.2019.6471
5.
BhatiaD, BattulaS, Mikulich-GilbertsonS, et al.Cannabidiol-Only product use in pregnancy in the United States and Canada findings from the international cannabis policy study. Obstet Gynecol, 2024; 144(2):156–159; doi: 10.1097/AOG.0000000000005603
6.
RokebyACE, NataleBV, NataleDRC. Cannabinoids and the placenta: Receptors, signaling and outcomes. Placenta, 2023; 135:51–61; doi: 10.1016/j.placenta.2023.03.002
7.
PaulSE, HatoumAS, FineJD, et al.Associations between prenatal cannabis exposure and childhood outcomes: Results from the ABCD study. JAMA Psychiatry, 2021; 78(1):64–76; doi: 10.1001/jamapsychiatry.2020.2902
8.
RompalaG, NomuraY, HurdYL. Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring. Proc Natl Acad Sci U S A, 2021; 118(47):e2106115118; doi: 10.1073/pnas.2106115118
9.
de AlmeidaDL, DeviLA. Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect, 2020; 8(6):e00682; doi: 10.1002/prp2.682
DevinskyO, PatelAD, CrossJH, et al.; GWPCARE3 Study Group. Effect of Cannabidiol on drop seizures in the lennox–gastaut syndrome. N Engl J Med, 2018; 378(20):1888–1897; doi: 10.1056/nejmoa1714631
12.
CheahM, FawcettJ, AndrewsM. Assessment of thermal pain sensation in rats and mice using the hargreaves test. Bio Protoc, 2017; 7(16):e2506; doi: 10.21769/BioProtoc.2506
13.
BatesEA, NikaiT, BrennanKC, et al.Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice. Cephalalgia, 2010; 30(2):170–178; doi: 10.1111/j.1468-2982.2009.01864.x
14.
HargreavesK, DubnerR, BrownF, et al.A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 1988; 32(1):77–88; doi: 10.1016/0304-3959(88)90026-7
PorsoltRD, Le PichonM, JalfreM. Depression: A new animal model sensitive to antidepressant treatments. Nature, 1977; 266(5604):730–732; doi: 10.1038/266730a0
17.
O’ConnorAM, BurtonTJ, LeameyCA, et al.The use of the puzzle box as a means of assessing the efficacy of environmental enrichment. J Vis Exp, 2014; 94:e52225; doi: 10.3791/52225
18.
CastagnéV, MoserP, RouxS, et al.Rodent models of depression: Forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Pharmacol, 2010;Chapter 5(1):Unit 5.8–Unit 5.8.14; doi: 10.1002/0471141755.ph0508s49
19.
YanZ, ReinB. Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: Pathophysiological implications. Mol Psychiatry, 2022; 27(1):445–465; doi: 10.1038/s41380-021-01092-3
20.
MenonV, D’EspositoM. The role of PFC networks in cognitive control and executive function. Neuropsychopharmacology, 2022; 47(1):90–103; doi: 10.1038/s41386-021-01152-w
21.
DeVuonoMV, NashedMG, SarikahyaMH, et al.Prenatal tetrahydrocannabinol and cannabidiol exposure produce sex-specific pathophysiological phenotypes in the adolescent prefrontal cortex and hippocampus. Neurobiol Dis, 2024; 199:106588; doi: 10.1016/j.nbd.2024.106588
22.
IezziD, Caceres-RodriguezA, ChavisP, et al.In utero exposure to cannabidiol disrupts select early-life behaviors in a sex-specific manner. Transl Psychiatry, 2022; 12(1):501; doi: 10.1038/s41398-022-02271-8
23.
CompagnoMK, SilverCR, Cox-HolmesA, et al.Maternal ingestion of Cannabidiol (CBD) in mice leads to sex-dependent changes in memory, anxiety, and metabolism in the adult offspring, and causes a decrease in survival to weaning age. Pharmacol Biochem Behav, 2025; 247:173902; doi: 10.1016/j.pbb.2024.173902
24.
IezziD, Cáceres-RodríguezA, ChavisP, et al.Sex-specific disruptions in the developmental trajectory of anxiety-like behaviors due to prenatal cannabidiol exposure. Transl Psychiatry, 2025; 15(1):354; doi: 10.1038/s41398-025-03517-x
25.
MacielIdS, AbreuG D, JohnsonCT, et al.Perinatal CBD or THC exposure results in lasting resistance to fluoxetine in the forced swim test: Reversal by fatty acid amide hydrolase inhibition. Cannabis Cannabinoid Res, 2022; 7(3):318–327; doi: 10.1089/can.2021.0015
26.
Bar-PeledO, Gross-IsseroffR, Ben-HurH, et al.Fetal human brain exhibits a prenatal peak in the density of serotonin 5-HT1A receptors. Neurosci Lett, 1991; 127(2):173–176; doi: 10.1016/0304-3940(91)90787-t
27.
BonninA, PengW, HewlettW, et al.Expression mapping of 5-HT1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development. Neuroscience, 2006; 141(2):781–794; doi: 10.1016/j.neuroscience.2006.04.036
28.
SarginD, JeoungHS, GoodfellowNM, et al.Serotonin regulation of the prefrontal cortex: Cognitive relevance and the impact of developmental perturbation. ACS Chem Neurosci, 2019; 10(7):3078–3093; doi: 10.1021/acschemneuro.9b00073
29.
GoodfellowNM, BenekareddyM, VaidyaVA, et al.Layer II/III of the prefrontal cortex: Inhibition by the serotonin 5-HT1A receptor in development and stress. J Neurosci, 2009; 29(32):10094–10103; doi: 10.1523/JNEUROSCI.1960-09.2009
30.
AltieriSC, Garcia-GarciaAL, LeonardoED, et al.Rethinking 5-HT1A receptors: Emerging modes of inhibitory feedback of relevance to emotion-related behavior. ACS Chem Neurosci, 2013; 4(1):72–83; doi: 10.1021/cn3002174
31.
BéïqueJC, CampbellB, PerringP, et al.Serotonergic regulation of membrane potential in developing rat prefrontal cortex: Coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. J Neurosci, 2004; 24(20):4807–4817; doi: 10.1523/JNEUROSCI.5113-03.2004
32.
AlexanderC, JeonJ, NickersonK, et al.CBD and the 5-HT1A receptor: A medicinal and pharmacological review. Biochem Pharmacol, 2025; 233:116742; doi: 10.1016/j.bcp.2025.116742
33.
RussoEB, BurnettA, HallB, et al.Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res, 2005; 30(8):1037–1043; doi: 10.1007/s11064-005-6978-1
34.
BatesE, OhWC. Molecular targets of cannabidiol warn against its consumption during pregnancy. MRAJ, 2024; 12(5); doi: 10.18103/mra.v12i5.5450
35.
HardingEK, SouzaIA, GandiniMA, et al.Differential regulation of Cav3. 2 and Cav2. 2 calcium channels by CB1 receptors and cannabidiol. Br J Pharmacol, 2023; 180(12):1616–1633.
36.
HuangJ, FanX, JinX, et al.Cannabidiol inhibits Nav channels through two distinct binding sites. Nat Commun, 2023; 14(1):3613.
37.
GhovanlooMR, ShuartNG, MezeyovaJ, et al.Inhibitory effects of cannabidiol on voltage-dependent sodium currents. J Biol Chem, 2018; 293(43):16546–16558.
38.
IacobasDA, IacobasS, LeePR, et al.Coordinated activity of transcriptional networks responding to the pattern of action potential firing in neurons. Genes (Basel), 2019; 10(10):754; doi: 10.3390/genes10100754
39.
TyssowskiKM, DeStefinoNR, ChoJH, et al.Different neuronal activity patterns induce different gene expression programs. Neuron, 2018; 98(3):530–546.e11; doi: 10.1016/j.neuron.2018.04.001
40.
LeePR, CohenJE, IacobasDA, et al.Gene networks activated by specific patterns of action potentials in dorsal root ganglia neurons. Sci Rep, 2017; 7(1):43765; doi: 10.1038/srep43765
41.
YapEL, GreenbergME. Activity-Regulated transcription: Bridging the gap between neural activity and behavior. Neuron, 2018; 100(2):330–348; doi: 10.1016/j.neuron.2018.10.013
42.
DahalGR, RawsonJ, GassawayB, et al.An inwardly rectifying K+ channel is required for patterning. Development, 2012; 139(19):3653–3664; doi: 10.1242/dev.078592
BerkeB, WittnamJ, McNeillE, et al.Retrograde BMP signaling at the synapse: A permissive signal for synapse maturation and activity-dependent plasticity. J Neurosci, 2013; 33(45):17937–17950; doi: 10.1523/JNEUROSCI.6075-11.2013
46.
SamantaJ, KesslerJA. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development, 2004; 131(17):4131–4142; doi: 10.1242/dev.01273
47.
MukhopadhyayA, McGuireT, PengCY, et al.Differential effects of BMP signaling on parvalbumin and somatostatin interneuron differentiation. Development, 2009; 136(15):2633–2642; doi: 10.1242/dev.034439
48.
CherifH, ArgawA, CécyreB, et al.Role of GPR55 during axon growth and target innervation. eNeuro, 2015; 2(5):ENEURO.0011–15.2015; doi: 10.1523/ENEURO.0011-15.2015
